Document is current
Any future updates will be listed below
-
Authors
Steimer, Annik https://orcid.org/0009-0009-5896-2230
Götschi, Andrea
Witte, Torsten
Scherer, Almut
Brändli, Jonas
Nissen, Michael J.
Möller, Burkhard
Grosswiler, Simon
Kyburz, Diego
Dan, Diana
Rubbert-Roth, Andrea
Adler, Sabine
Distler, Oliver
Baraliakos, Xenofon
Ciurea, Adrian
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 23 December 2024
Revised: 19 February 2025
Accepted: 27 February 2025
First Online: 10 March 2025
Declarations
:
: The study has been approved by the ethics committee and has therefore been performed in accordance with the ethical standards laid down in the Declaration of Helsinki. All persons gave their informed consent prior to the inclusion in the study.
: AnS is supported by the MLR foundation.AG: None.TW: Honoraria for lectures and consultation from Abbvie, Alfasigma, Amgen, Janssen, Lilly, Medac, MSD, Novartis, Pfizer, UCB. Patent on CD74 autoantibody measurement.AlS: None.JB: None.MJN: Honoraria for lectures and consultation from Abbvie, Janssen, Eli Lilly, Novartis, Pfizer, and UCB.BM: None.SG: None.DK: Honoraria for lectures and consultation from Abbvie, Eli-Lilly, Janssen, Novartis, Pfizer, Roche, Sanofi.DD: None.ARR: Honoraria for lectures and consultation from Abbvie, Janssen, MSD, Novartis, Pfizer, UCB.SA: None.OD: None.XB: None.AC: None.
